A recent animal model of AIH, using transgenic mice on the non-obese diabetic (NOD) background carrying human HLA-DR3 and immunized with a DNA plasmid coding for a fusion protein of human CYP2D6/FTCD – the autoantigens targeted in AIH type 2 -, showed. The gene discussed is FTCD; the disease is autoimmune hepatitis.